Request Call Back
Endoscopic Sclerotherapy: A Targeted Approach for Treating Digestive System Variceal Bleeding
What is Endoscopic Sclerotherapy?
Endoscopic sclerotherapy is a minimally invasive therapeutic procedure used to manage bleeding from varicose veins (varices) in the gastrointestinal (GI) tract, most commonly in the esophagus and stomach. In this technique, a sclerosing agent—a chemical substance that causes localized inflammation and fibrosis—is injected directly into or around the varices using an endoscope.
The goal of sclerotherapy is to:
· Induce scarring and closure of the dilated vessels.
· Stop active bleeding or reduce the risk of future bleeding.
· Minimize the need for emergency surgery in high-risk patients.
This procedure is typically performed under sedation. It requires no external incisions, and patients often recover quickly and can return home the same day.
Although band ligation has become the preferred treatment for esophageal varices in many centers, sclerotherapy remains an important and sometimes essential tool, especially in patients where ligation is not feasible or effective.
In Which Cases Is Sclerotherapy Preferred?
Endoscopic sclerotherapy is a life-saving intervention in several clinical scenarios involving GI bleeding due to varices. It is especially important in managing complications of portal hypertension, most often caused by liver cirrhosis.
1. Esophageal Varices
· Emergency Treatment: Sclerotherapy is used to stop active bleeding from esophageal varices—a potentially fatal complication of portal hypertension.
· Prophylactic Treatment: In patients with known esophageal varices and a high risk of bleeding, sclerotherapy may be used to prevent future hemorrhages.
· Post-Ligation Recurrence: It is also used in patients who have recurrent bleeding after band ligation or in cases where the varices are not suitable for banding.
2. Gastric Varices
· Fundal varices (in the upper part of the stomach) are less accessible for band ligation.
· Sclerotherapy or glue injection techniques may be preferred for controlling bleeding in these areas.
3. Other Variceal Locations
· Rectal varices or ectopic varices (e.g., duodenum, jejunum) caused by portal hypertension may also be treated with sclerotherapy when indicated.
4. Technical Limitations or Special Patient Conditions
Sclerotherapy is often the treatment of choice in situations where:
· Band ligation is technically difficult due to location or size of the varix.
· There are multiple or diffuse varices.
· The patient has coagulopathy or other conditions limiting the use of mechanical techniques.
How is the Procedure Performed?
Endoscopic sclerotherapy is a safe and efficient procedure when conducted by an experienced endoscopist.
Step-by-Step Overview:
1. Patient Preparation:
o Fasting for 6–8 hours prior to the procedure.
o Sedation or conscious anesthesia to ensure comfort.
2. Endoscope Introduction:
o A flexible endoscope is guided through the mouth to the esophagus or stomach.
3. Identification of Varices:
o The varices are visualized and assessed for active bleeding or rupture risk.
4. Sclerosing Agent Injection:
o A needle is passed through the endoscope channel.
o The sclerosing agent (commonly ethanolamine oleate, sodium tetradecyl sulfate, or polidocanol) is injected intra-variceally (into the vein) or peri-variceally (around the vein).
o This leads to inflammation, fibrosis, and eventual collapse of the variceal wall.
5. Post-Procedure Monitoring:
o Patients are observed for 1–2 hours after the procedure.
o Diet is gradually reintroduced, usually starting with clear liquids.
The entire procedure typically takes 20 to 30 minutes.
Risks and Complications
While sclerotherapy is considered generally safe, it can be associated with a few rare but significant complications:
· Mild side effects:
o Chest pain
o Sore throat
o Low-grade fever
· Potential complications:
o Ulceration at the injection site
o Esophageal stricture (narrowing)
o Re-bleeding
o Perforation (extremely rare)
o Infection or localized inflammation
To minimize these risks:
· The procedure must be performed by a skilled endoscopist.
· Patients should be treated in appropriately equipped centers.
· Close post-procedure monitoring and follow-up endoscopies are essential.
Follow-Up and Long-Term Management
After the initial sclerotherapy session, repeat procedures may be required, especially in patients with ongoing portal hypertension or high recurrence risk.
Long-Term Follow-Up Includes:
· Repeat endoscopy at scheduled intervals to monitor for residual or new varices.
· Medical therapy, such as non-selective beta-blockers (e.g., propranolol or nadolol), to reduce portal pressure.
· Lifestyle adjustments to reduce liver stress and manage underlying liver disease.
In some patients, additional therapies such as transjugular intrahepatic portosystemic shunt (TIPS) or liver transplantation may eventually be considered, depending on disease progression.
Conclusion
Endoscopic sclerotherapy remains a valuable and effective treatment for gastrointestinal bleeding caused by varices, particularly in the esophagus and stomach. While its use has declined with the advent of band ligation, it continues to play a critical role in emergency bleeding control and as an alternative when banding is not feasible.
When applied with the right indications, by experienced professionals, and followed by appropriate monitoring and medical management, sclerotherapy can significantly reduce the risk of life-threatening bleeding and improve the overall prognosis and quality of life in patients with portal hypertension and variceal disease.
